Lung Cancer
Lung cancer patients carry key genetic mutations in pleural effusions
Published in Genomics and Genetics Weekly, August 11th, 2006
"Epidermal growth factor receptor (EGFR) mutations are a strong determinant of tumor response to gefitinib in non-small cell lung cancer (NSCLC). We attempted to elucidate the feasibility of EGFR mutation detection in cells of pleural effusion fluid," scientists writing in the journal Cancer Science report.
"We obtained 24 samples of pleural effusion fluid from NSCLC patients. The pleural effusion fluid was centrifuged, and the cellular components obtained were used for detection. EGFR mutation status was determined by a direct sequencing method (exons 18-21) and by the...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Genomics and Genetics Weekly
More Articles from Genomics and Genetics Weekly
- Cardiomyocytes
Contractility, calcium handling are impaired by 70-kDA heat shock protein gene deletion in mice - Diabetes Genetics & Genomics
Kir6.2 gene mutations in R50 residue cause neonatal diabetes plus different functional effects - Liver Cancer
Aggressive liver cancers are defined by Met gene signatures - Age-Related Macular Degeneration
The risk for age-related macular degeneration is raised by complement factor H variation - Allergy & Immunology
Allergic inflammation is modified by different bacterial ligands in a rhinitis model - Apoptosis
Apoptosis is induced in colon cancer cells following protein dissociation - More from this issue of Genomics and Genetics Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
